dalteparin has been researched along with Hypertrophy in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Hypertrophy: General increase in bulk of a part or organ due to CELL ENLARGEMENT and accumulation of FLUIDS AND SECRETIONS, not due to tumor formation, nor to an increase in the number of cells (HYPERPLASIA).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schaal, JV | 1 |
| Benhamou, D | 1 |
| Boyer, K | 1 |
| Mercier, FJ | 1 |
1 other study available for dalteparin and Hypertrophy
| Article | Year |
|---|---|
[Parkes-Weber syndrome and pregnancy: anaesthetic implications].
Topics: Adult; Analgesia, Epidural; Analgesia, Obstetrical; Anticoagulants; Arteriovenous Malformations; Emb | 2013 |